期刊
CURRENT GENE THERAPY
卷 14, 期 1, 页码 2-9出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/156652321402140318165450
关键词
Zinc finger nucleases; TALENs; CRISPR; disease modeling; gene therapy; review
资金
- Novartis Institutes for Biomedical Research, Inc.
The development of custom-designed nucleases (CDNs), including zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs), has made it possible to perform precise genetic engineering in many cell types and species. More recently, clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) system has been successfully employed for genome editing. These RNA-guided DNA endonucleases are shown to be more efficient and flexible than CDNs and hold great potential for applications in both biological studies and medicine. Here, we review the progress that has been made for all three genome editing technologies in modifying both cells and model organisms, compare important aspects of each approach, and summarize the applications of these tools in disease modeling and gene therapy. In the end, we discuss future prospects of the field.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据